ProMIS Neurosciencesの収入
ProMIS Neurosciencesの収入 は何ですか。
ProMIS Neurosciences, Inc.の収入 は-7.65$です。
収入 の定義は何ですか。
普通株主に帰属する当期純利益は、純利益から優先配当金を差し引いた金額です。優先配当
Net income available to common shareholders are the profits remaining after the company pays all of its suppliers, employees, service providers, creditors, and preferred shareholders. In other words, this is revenue less all expenses and preferred dividends. The number measures common shareholders' claim on the company's cash flows.
TSXのセクタHealth Careにおける収入 の企業と比べるProMIS Neurosciences
ProMIS Neurosciencesは何をしますか。
ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins. Its lead product candidates include PMN310, a monoclonal antibody (mAb) for toxic oligomers in AD; PMN267, a superoxide dismustase 1 and TAR-DNA binding protein 43 in ALS, as well as alpha synuclein in Parkinson's disease and Lewy body dementia; and PMN442, a mAb targeting toxic a-syn oligomers and seeding fibrils in MSA. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. was incorporated in 2004 and is headquartered in Toronto, Canada.
ProMIS Neurosciencesと類似の収入
- Aurion Resourcesの収入 は-7.68CAD$です。
- Eyecarrot Innovationsの収入 は-7.68CAD$です。
- PharmAustの収入 は-7.68AUD$です。
- Maple Gold Minesの収入 は-7.67CAD$です。
- Magnetic Resources NLの収入 は-7.66AUD$です。
- Select Interior Conceptsの収入 は-7.66$です。
- ProMIS Neurosciencesの収入 は-7.65$です。
- BRCの収入 は-7.65$です。
- Atlas Incの収入 は-7.65$です。
- Seven Acesの収入 は-7.65$です。
- Kromek Plcの収入 は-7.64£です。
- IncentiaPayの収入 は-7.64AUD$です。
- The Tinley Beverage Coの収入 は-7.64CAD$です。